Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?

Diabetologia. 2012 Dec;55(12):3392-5. doi: 10.1007/s00125-012-2724-9. Epub 2012 Sep 20.

Authors

N Rudovich¹, O Pivovarova, A Traberth, A Sparwasser, M O Weickert, W Bernigau, A L Birkenfeld, A M Arafat, A Bergmann, A F H Pfeiffer

Affiliation

¹ Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam, Arthur-Scheunert-Allee 114-116, Nuthetal, Germany. [email protected]

PMID: 22990716
DOI: 10.1007/s00125-012-2724-9

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Acarbose / pharmacology*
Atrial Natriuretic Factor / blood
Atrial Natriuretic Factor / drug effects*
Blood Glucose / drug effects*
Cross-Over Studies
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / drug therapy*
Double-Blind Method
Female
Glycated Hemoglobin / drug effects*
Humans
Hypoglycemic Agents / pharmacology*
Male
Middle Aged
Postprandial Period
Protein Precursors / blood
Protein Precursors / drug effects*

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
N-terminal proatrial natriuretic peptide
Protein Precursors
hemoglobin A1c protein, human
Atrial Natriuretic Factor
Acarbose

Associated data

ISRCTN/ISRCTN40281673